http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107693516-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-04 |
| filingDate | 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107693516-B |
| titleOfInvention | Deferasirox pharmaceutical composition, pharmaceutical preparation, preparation method and application thereof |
| abstract | The invention relates to a pharmaceutical composition, a pharmaceutical preparation thereof, a preparation method and application. The pharmaceutical composition comprises the active ingredient deferasirox and a carrier material hydroxypropyl methylcellulose derivative and optionally a non-ionic surfactant. The pharmaceutical preparation is in the form of an oral solid preparation. The pharmaceutical composition and the pharmaceutical preparation thereof can be used for preparing a medicament for preventing or treating chronic iron overload. |
| priorityDate | 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.